These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11134212)

  • 21. Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.
    Anderlini P; Benjamin RS; Wong FC; Kantarjian HM; Andreeff M; Kornblau SM; O'Brien S; Mackay B; Ewer MS; Pierce SA
    J Clin Oncol; 1995 Nov; 13(11):2827-34. PubMed ID: 7595745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
    Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
    J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term risk of congestive heart failure in younger breast cancer survivors: A nationwide study by the SMARTSHIP group.
    Lee J; Hur H; Lee JW; Youn HJ; Han K; Kim NW; Jung SY; Kim Z; Kim KS; Lee MH; Han SH; Jung SH; Chung IY
    Cancer; 2020 Jan; 126(1):181-188. PubMed ID: 31454422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.
    Creutzig U; Diekamp S; Zimmermann M; Reinhardt D
    Pediatr Blood Cancer; 2007 Jun; 48(7):651-62. PubMed ID: 17183582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late cardiotoxicity of anthracyclines in children with acute leukemia.
    Zalewska-Szewczyk B; Lipiec J; Bodalski J
    Klin Padiatr; 1999; 211(4):356-9. PubMed ID: 10472576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart Failure in Relation to Anthracyclines and Other Chemotherapies.
    Agunbiade TA; Zaghlol RY; Barac A
    Methodist Debakey Cardiovasc J; 2019; 15(4):243-249. PubMed ID: 31988684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
    Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
    J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of clinical congestive heart failure induced by anthracycline chemotherapy.
    Moreb JS; Oblon DJ
    Cancer; 1992 Dec; 70(11):2637-41. PubMed ID: 1423193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
    J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up.
    Oztarhan K; Guler S; Aktas B; Arslan M; Salcioglu Z; Aydogan G
    Pediatr Hematol Oncol; 2011 Aug; 28(5):380-94. PubMed ID: 21699467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
    Ekstein S; Nir A; Rein AJ; Perles Z; Bar-Oz B; Salpeter L; Algur N; Weintraub M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.
    Krum H; Curtis SP; Kaur A; Wang H; Smugar SS; Weir MR; Laine L; Brater DC; Cannon CP
    Eur J Heart Fail; 2009 Jun; 11(6):542-50. PubMed ID: 19380329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac complications in childhood cancer survivors treated with anthracyclines.
    Franco VI; Lipshultz SE
    Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congestive heart failure among children with acute leukemia: a population-based matched cohort study.
    Chellapandian D; Pole JD; Nathan PC; Sung L
    Leuk Lymphoma; 2019 Feb; 60(2):385-394. PubMed ID: 29966479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors.
    Gennari A; Salvadori B; Donati S; Bengala C; Orlandini C; Danesi R; Del Tacca M; Bruzzi P; Conte PF
    J Clin Oncol; 1999 Nov; 17(11):3596-602. PubMed ID: 10550159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.
    Nysom K; Holm K; Lipsitz SR; Mone SM; Colan SD; Orav EJ; Sallan SE; Olsen JH; Hertz H; Jacobsen JR; Lipshultz SE
    J Clin Oncol; 1998 Feb; 16(2):545-50. PubMed ID: 9469339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
    Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
    Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.